SXT Stock Analysis: Buy, Sell, or Hold?

SXT - Sensient Technology Corporation

INDUSTRIAL ORGANIC CHEMICALS
$94.52
-1.08 (-1.13%) β–Ό
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 13, 2026 12d

Get Alerted When SXT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
βœ… BUY SIGNAL: SXT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$139.55
Based on 8.0% avg growth
INTRINSIC VALUE TODAY
$86.65
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 24.1x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: SXT is currently trading at $94.52, which is considered slightly low relative to its 30-day fair value range of $94.41 to $97.24. The stock's valuation (Forward PE: 24.2) is in line with its historical norms (24.1). At these levels, the market is pricing in 0.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, SXT is in a strong uptrend. The price is currently testing key support at $93.49. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (18th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $120.00 (+25.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY LOW
Fair Price Range $94.41 - $97.24
Company Quality Score 59/100 (HOLD)
Options IV Signal 18th percentile (LOW)
Volume Confirmation HIGH
Confidence Score 84.2%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 18th percentile)
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 25.5% below Wall St target ($120.00)
  • NEUTRAL: Market pricing in 0.0% annual earnings growth - fairly valued

Fair Price Analysis

30-Day Fair Range $94.41 - $97.24
Current vs Fair Value SLIGHTLY LOW
Expected Move (7 Days) Β±$4.36 (4.6%)

Support & Resistance Levels

Support Level $93.49
Resistance Level $98.87
Current Trend Strong Uptrend

Fundamental Context

Forward P/E (Next Year Est.) 24.16
Wall Street Target $120.00 (+25.5%)
Revenue Growth (YoY) 5.0%
Earnings Growth (YoY) 13.0%
Profit Margin 8.7%
PE vs Historical 24.2 vs 24.1 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): 0% (market-implied from PE analysis)
1-Year Target $95.60 (0%)
2-Year Target $95.60 (0%)
3-Year Target $95.60 (0%)
3-Yr Target (if PE normalizes) (PE: 24β†’24) PE COMPRESSION $95.36 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 24.2, Growth: 11.9%) $133.86 (+40%)
Base: (SPY PE: 22.3, Growth: 11.9%) $123.55 (+29%)
Bear: (PE: 19.0, Growth: 11.9%) $105.02 (+10%)
πŸ“ˆ Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (29x PE), but valuation improves significantly next year (24x PE) as earnings recover.
Trailing PE: 29.07 | Current EPS (TTM): $3.27
Bull Case $126.52 (+34%)
Analyst growth 21.0%, PE expands to 32.0
Base Case $115.02 (+22%)
Market implied 21.0%, PE stable at 29.1
Bear Case $64.64 (-32%)
Severe decline -20.0%, PE contracts to 24.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 31, 2026 2:04 AM ET
Data refreshes hourly during market hours. Next update: 3:04 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Paul Manning BUY 20 shares 2025-08-11
Sharad P Jain SELL 1 shares 2025-08-06

Top Rated Specialty Chemicals Stocks

Top-rated stocks in Specialty Chemicals by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
LIN
Linde plc Ordinary Shares
BUY
28 analysts
$505 63 BUY
SHW
Sherwin-Williams Co
BUY
28 analysts
$386 61 BUY
DD
Dupont De Nemours Inc
STRONG BUY
20 analysts
$49 65 BUY
APD
Air Products and Chemica…
BUY
24 analysts
$294 66 BUY
IFF
International Flavors & …
STRONG BUY
22 analysts
$82 60 HOLD

Advanced SXT Option Strategies

Professional options setups generated by AI based on today's SXT price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for SXT

SXT Technical Chart SXT Price Prediction SXT Earnings Date SXT Investment Advisor SXT Fair Price Analyzer SXT Options Advisor SXT Options Chain SXT Options Analysis SXT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals